Loading clinical trials...
Loading clinical trials...
Combined Systemic and Intrathecal Chemotherapy Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation for CNS Relapse of Aggressive Lymphomas
Conditions
Interventions
Combined systemic and intrathecal chemotherapy followed by HD-ASCT
Locations
1
Germany
Charité Universitätsmedizin
Berlin, State of Berlin, Germany
Start Date
October 1, 2007
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2012
Last Updated
June 22, 2010
NCT06510361
NCT05442515
NCT07162181
NCT06528301
NCT05824585
NCT04460235
Lead Sponsor
Charite University, Berlin, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions